Patents by Inventor Gerald Wynn Hallworth

Gerald Wynn Hallworth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhalation composition containing lactose pellets
    Patent number: 6955824
    Abstract: This invention relates to a pharmaceutical composition which is suitable for the administration of medicaments by inhalation. In particular, the pharmaceutical composition comprises microfine particles of medicament and at least one lactose pellet having a diameter of from about 10 to about 1500 micrometers, which pellet comprises a plurality of microfine lactose particles. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of medicament selected from the group consisting of anti-allergics, bronchodilators, anti-inflammatory steroids and mixtures thereof in the pharmaceutical composition as defined is described also.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: October 18, 2005
    Assignee: Glaxo Group Limited
    Inventor: Gerald Wynn Hallworth
  • Inhalation composition containing lactose pellets
    Patent number: 6183782
    Abstract: The present invention relates to a pharmaceutical composition which is suitable for the administration of medicaments by inhalation. In particular, the pharmaceutical composition comprises microfine particles of medicament and at least one lactose pellet having a diameter of from about 10 to about 1500 micrometers, which pellet comprises a plurality of microfine lactose particles. A method of treating respiratory disorders which comprises administration by inhalation of an effective amount of medicament selected from the group consisting of anti-allergics, bronchodilators, anti-inflammatory steroids and mixtures thereof in the pharmaceutical composition as defined is also described.
    Type: Grant
    Filed: September 13, 1996
    Date of Patent: February 6, 2001
    Assignee: Glaxo Group Limited
    Inventor: Gerald Wynn Hallworth